Literature DB >> 27873719

Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now?

B Edwards1, R Andini2, S Esposito3, P Grossi4, D Lew5, T Mazzei6, A Novelli6, A Soriano7, I M Gould8.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) infection continues to be a substantial global problem with significant associated morbidity and mortality. This review summarises the discussions that took place at the 4th MRSA Consensus Conference in relation to the current treatment options for serious MRSA infections and how to optimise whichever therapy is embarked upon. It highlights the many challenges faced by both the laboratory and clinicians in the diagnosis and treatment of MRSA infections. Copyright Â
© 2014 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  MRSA; Susceptibility testing; Treatment

Year:  2014        PMID： 27873719     DOI： 10.1016/j.jgar.2014.03.009

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN： 2213-7165            Impact factor:   4.035


  8 in total

1.  Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection.

Authors:  Yue Zhang; Jianhua Zhang; Wansong Chen; Pavimol Angsantikul; Kevin A Spiekermann; Ronnie H Fang; Weiwei Gao; Liangfang Zhang
Journal:  J Control Release       Date:  2017-01-10       Impact factor: 9.776

2.  Antibacterial mode of action of violacein from Chromobacterium violaceum UTM5 against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Claira Arul Aruldass; Santhana Raj Louis Masalamany; Chidambaram Kulandaisamy Venil; Wan Azlina Ahmad
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-31       Impact factor: 4.223

3.  Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.

Authors:  Chiu-Fai Kuok; Sai-On Hoi; Chi-Fai Hoi; Chi-Hong Chan; Io-Hong Fong; Cheong-Kei Ngok; Li-Rong Meng; Pedro Fong
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

4.  The NaHCO3-Responsive Phenotype in Methicillin-Resistant Staphylococcus aureus (MRSA) Is Influenced by mecA Genotype.

Authors:  Selvi C Ersoy; Adhar C Manna; Arnold S Bayer; Ambrose Cheung; Richard A Proctor; Henry F Chambers; Ewan M Harrison
Journal:  Antimicrob Agents Chemother       Date:  2022-05-16       Impact factor: 5.938

5.  Bicarbonate Resensitization of Methicillin-Resistant Staphylococcus aureus to β-Lactam Antibiotics.

Authors:  Selvi C Ersoy; Wessam Abdelhady; Liang Li; Henry F Chambers; Yan Q Xiong; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

6.  Impact of Bicarbonate on PBP2a Production, Maturation, and Functionality in Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Selvi C Ersoy; Henry F Chambers; Richard A Proctor; Adriana E Rosato; Nagendra N Mishra; Yan Q Xiong; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2021-03-01       Impact factor: 5.191

7.  Impact of Bicarbonate-β-Lactam Exposures on Methicillin-Resistant Staphylococcus aureus (MRSA) Gene Expression in Bicarbonate-β-Lactam-Responsive vs. Non-Responsive Strains.

Authors:  Selvi C Ersoy; Blake M Hanson; Richard A Proctor; Cesar A Arias; Truc T Tran; Henry F Chambers; Arnold S Bayer
Journal:  Genes (Basel)       Date:  2021-10-20       Impact factor: 4.096

8.  Integrated Metabolomic, Molecular Networking, and Genome Mining Analyses Uncover Novel Angucyclines From Streptomyces sp. RO-S4 Strain Isolated From Bejaia Bay, Algeria.

Authors:  Rima Ouchene; Didier Stien; Juliette Segret; Mouloud Kecha; Alice M S Rodrigues; Carole Veckerlé; Marcelino T Suzuki
Journal:  Front Microbiol       Date:  2022-06-23       Impact factor: 6.064
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.